Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ohad Atia

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|May 23, 2020
Role of Thiopurines in Pediatric Inflammatory Bowel Diseases: A Real-Life Prospective Cohort StudyOhad Atia, Oren Ledder, Tehila Ben-Moshe, et al.
Journal of Crohn'S & Colitis|February 26, 2024
The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide CohortsOhad Atia, Nicklas Bryder, Adi Mendelovici, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 22, 2022
Perianal Crohn Disease Is More Common in Children and Is Associated With Complicated Disease Course Despite Higher Utilization of Biologics: A Population-based Study From The epidemiology group of the Israeli IBD Research Nucleus (epiIIRN)Ohad Atia, Gili Focht, Rona Lujan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2021
Perianal Crohn's Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN CohortOhad Atia, Noa Asayag, Gili Focht, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
Inflammatory Bowel Diseases|January 8, 2024
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN CohortOhad Atia, Chagit Friss, Gili Focht, et al.
Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.
Journal of Crohn'S & Colitis|July 19, 2023
Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRNOhad Atia, Chagit Friss, Gili Focht, et al.
Journal of Crohn'S & Colitis|November 18, 2021
Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRNOhad Atia, Sasha Harel, Natan Ledderman, et al.
Inflammatory Bowel Diseases|April 5, 2024
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRNOhad Atia, Chagit Friss, Gili Focht, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Pediatric Gastroenterology and Nutrition|May 23, 2020
Role of Thiopurines in Pediatric Inflammatory Bowel Diseases: A Real-Life Prospective Cohort StudyOhad Atia, Oren Ledder, Tehila Ben-Moshe, et al.
Journal of Crohn'S & Colitis|February 26, 2024
The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide CohortsOhad Atia, Nicklas Bryder, Adi Mendelovici, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 22, 2022
Perianal Crohn Disease Is More Common in Children and Is Associated With Complicated Disease Course Despite Higher Utilization of Biologics: A Population-based Study From The epidemiology group of the Israeli IBD Research Nucleus (epiIIRN)Ohad Atia, Gili Focht, Rona Lujan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2021
Perianal Crohn's Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN CohortOhad Atia, Noa Asayag, Gili Focht, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
Inflammatory Bowel Diseases|January 8, 2024
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN CohortOhad Atia, Chagit Friss, Gili Focht, et al.
Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.
Journal of Crohn'S & Colitis|July 19, 2023
Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRNOhad Atia, Chagit Friss, Gili Focht, et al.
Journal of Crohn'S & Colitis|November 18, 2021
Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRNOhad Atia, Sasha Harel, Natan Ledderman, et al.
Inflammatory Bowel Diseases|April 5, 2024
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRNOhad Atia, Chagit Friss, Gili Focht, et al.
Pageof 4